Meeting
2024 ASCO Gastrointestinal Cancers Symposium
A single-institution experience of acute toxicities in patients treated with short course hypofractionated radiotherapy in locally advanced rectal cancer.
Authors
Katie Nadine Lee
Harvard Radiation Oncology Program, Boston, MA
Katie Nadine Lee , Shane Neibart , Alexander D. Droznin , Mai Anh Huynh , Christian V. Guthier , Brandon E. Turner , Neil E. Martin , Miranda B. Lam , Luke Peng , Peter C. Enzinger , Jeffrey A. Meyerhardt , Harvey J. Mamon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Symptoms, Toxicities, and Whole-Person Care
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 92)
DOI
10.1200/JCO.2024.42.3_suppl.92
Abstract #
92
Poster Bd #
F15
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Effect of neoadjuvant IMRT for locally advanced rectal cancer on toxicity and pathologic response.
First Author: John David
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Toxicities and outcomes of neoadjuvant treatment in elderly patients with locally advanced rectal cancer: A scoping review.
First Author: Ruba Ahmed Mohammed Hamed
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Phase II trial of organ preservation program using short-course radiation and folfoxiri for rectal cancer (SHORT-FOX).
First Author: Erqi L. Pollom
Poster
2024 ASCO Annual Meeting
Total neoadjuvant therapy with split-course hypofraction radiotherapy combined with CAPOX and envafolimab followed by local excision for locally advanced very low rectal cancer (TRACE-LE): An open-label, single-arm, multicenter, phase II trial.
First Author: Weizhong Jiang